Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Vanel

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2007
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patientsMarie-Cécile Le Deley, Jean-Marc Guinebretière, Jean-Claude Gentet, et al.
Cells|November 4, 2020
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective SeriesEmanuela Palmerini, Elisabetta Setola, Giovanni Grignani, et al.
Bulletin Du Cancer|November 4, 2005
[Recommendations for the management of GIST patients]Jean-Yves Blay, Bruno Landi, Sylvie Bonvalot, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2007
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patientsMarie-Cécile Le Deley, Jean-Marc Guinebretière, Jean-Claude Gentet, et al.
Cells|November 4, 2020
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective SeriesEmanuela Palmerini, Elisabetta Setola, Giovanni Grignani, et al.
Bulletin Du Cancer|November 4, 2005
[Recommendations for the management of GIST patients]Jean-Yves Blay, Bruno Landi, Sylvie Bonvalot, et al.
Pageof 10